Objective: To investigate the effect of miRNA-323-3p on cardiomyocyte apoptosis in rats with coronary heart disease and its possible mechanism. Methods: The SD rats were divided into Control group, Model group, NC agomir group, miR-323-3p agomir group, miR-323-3p agomir+pcDNA group, and miR-323-3p agomir+pcDNA-TGF-β2 group, 12 rats in each group. Except for the control group, rats in the other groups were fed with high-fat diet to construct a coronary heart disease rat model. After the modeling was successfully estabilshed, the corresponding agomir or pcDNA was injected into the tail vein for treatment, the control group and the model group were injected with the same amount of normal saline through the tail vein. Two weeks later, the changes in mean arterial pressure(MAP), left ventricular systolic pressure(LVSP), and heart rate(HR) of the rats' heart function indexes were measured; HE staining was used to detect the pathological changes of rat myocardial tissue; TUNEL staining was used to detect myocardial cell apoptosis in rats of each group; qRT-PCR was used to detect the miR-323-3p expression in rat myocardial tissue; Western blotting was used to detect the Bax, Bcl-2, transforming growth factor β2(TGF-β2) and phosphorylated c-Jun N-terminal kinase(p-JNK) protein expression in rat myocardial tissue; and dual luciferase reporter gene experiment was used to verify the relationship between miR-323-3p and TGF-β2. Results: Compared with the control group, the myocardial cells were swollen, with a large number of inflammatory cells infiltrating and myocardial fibers breaking, the MAP, LVSP, HR, and the miR-323-3p and Bcl-2 protein expression levels reduced significantly, and apoptosis rate, Bax, TGF-β2 and p-JNK protein expression levels increased significantly in the model group(P<0.05); compared with the model group and NC agomir group, the pathological changes of myocardial tissue were significantly reduced, the MAP, LVSP, HR, the miR-323-3p and Bcl-2 protein expression levels increased significantly, and apoptosis rate, Bax, the TGF-β2 and p-JNK protein expression levels reduced significantly in the miR-323-3p agomir group(P<0.05); compared with the miR-323-3p agomir group and the miR-323-3p agomir+pcDNA group, the pathological changes of myocardial tissue were significantly worse, the MAP, LVSP, HR, and the Bcl-2 protein expression level reduced significantly, and apoptosis rate, the Bax, TGF-β2 and p-JNK protein expression levels increased significantly in the miR-323-3p agomir+pcDNA-TGF-β2 group(P<0.05), while there was no statistically significant difference in the level of miR-323-3p(P>0.05); in addition, miR-323-3p targeted the regulation of the expression of TGF-β2. Conclusion: Overexpression of miR-323-3p may inhibit apoptosis of coronary heart disease rats by inhibiting the TGF-β2/JNK pathway. |
[1] LIN F, CHEN H W, ZHAO G A, et al.Advances in research on the circRNA-miRNA-mRNA network in coronary heart disease treated with traditional Chinese medicine[J].Evid Based Complement Alternat Med, 2020, 2020(1):1-10.
[2] MA L Y, CHEN W W, GAO R L, et al.China cardiovascular diseases report 2018:an updated summary[J].J Geriatr Cardiol, 2020, 17(1):1-8.
[3] XIANG Y, PENG J Q, LIU Q, et al.The association between CD69 and EGR1 levels, and CHD patients without reflow after PCI[J].Exp Ther Med, 2019, 17(5):3913-3920.
[4] YIN H, LIU Y, MA H, et al.Associations of mood symptoms with NYHA functional classes in angina pectoris patients:a cross-sectional study[J].BMC Psychiatry, 2019, 19(1):85-97.
[5] QIN J, SUN Y, LIU S, et al.MicroRNA-323-3p promotes myogenesis by targeting Smad2[J].J Cell Biochem, 2019, 120(11):18751-18761.
[6] ZHAO Y, TAO M, WEI M, et al.Mesenchymal stem cells derived exosomal miR-323-3p promotes proliferation and inhibits apoptosis of cumulus cells in polycystic ovary syndrome(PCOS)[J].Artif Cells Nanomed Biotechnol, 2019, 47(1):3804-3813.
[7] 郭伟伟, 张晓鹏, 李霞, 等.三七皂苷R1调控AMPK/Nrf-2/HO-1信号通路缓解冠心病大鼠心肌损伤的研究[J].中国现代应用药学, 2021, 38(1):36-41.
[8] JIAN W, LI L, WEI X M, et al.Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI[J].Medicine(Baltimore), 2019, 98(5):1-7.
[9] 蒋长荣, 马小峰.SATB1基因沉默介导NF-κB通路对冠心病小鼠主动脉内皮细胞炎症损伤的保护作用[J].东南大学学报(医学版), 2020, 39(1):35-40.
[10] RONG J, XU J, LIU Q, et al.Anti-inflammatory effect of up-regulated microRNA-221-3p on coronary heart disease via suppressing NLRP3/ASC/pro-caspase-1 inflammasome pathway activation[J].Cell Cycle, 2020, 19(12):1478-1491.
[11] TANG L, LIU L, LI G, et al.Expression profiles of long noncoding RNAs in intranasal LPS-mediated alzheimer's disease model in mice[J].Biomed Res Int, 2019, 2019(1):1-14.
[12] YANG X, HE T, HAN S, et al.The role of traditional chinese medicine in the regulation of oxidative stress in treating coronary heart disease[J].Oxid Med Cell Longev, 2019, 2019(1):1-13.
[13] FENG J, WANG M, LI M, et al.Serum miR-221-3p as a new potential biomarker for depressed mood in perioperative patients[J].Brain Res, 2019, 1720(1):146296-146327.
[14] JING R, ZHONG Q Q, LONG T Y, et al.Downregulated miRNA-26a-5p induces the apoptosis of endothelial cells in coronary heart disease by inhibiting PI3K/AKT pathway[J].Eur Rev Med Pharmacol Sci, 2019, 23(11):4940-4947.
[15] SHI C C, PAN L Y, ZHAO Y Q, et al.MicroRNA-323-3p inhibits oxidative stress and apoptosis after myocardial infarction by targeting TGF-β2/JNK pathway[J].Eur Rev Med Pharmacol Sci, 2020, 24(12):6961-6970.
[16] WANG T, LIU Y, LV M, et al.miR-323-3p regulates the steroidogenesis and cell apoptosis in polycystic ovary syndrome(PCOS) by targeting IGF-1[J].Gene, 2019, 683(1):87-100.
[17] MORIKAWA M, DERYNCK R, MIYAZONO K.TGF-β and the TGF-β family:context-dependent roles in cell and tissue physiology[J].Cold Spring Harb Perspect Biol, 2016, 8(5):1-24.
[18] 王凤仙.表没食子儿茶素没食子酸酯通过TGF-β1/JNK信号通路改善糖尿病大鼠心肌纤维化的作用及相关机制[D].锦州:锦州医科大学, 2018.
[19] 杨雅, 刘霞.木补对心肌缺血大鼠ST段及Omentin-1/iNOS和TGF-β1/JNK通路的影响[J].成都医学院学报, 2015, 10(1):31-34. |